Omada Health, Inc. (NASDAQ:OMDA) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Omada Health, Inc. (NASDAQ:OMDA) have earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $25.10.

A number of equities analysts have issued reports on OMDA shares. Needham & Company LLC increased their target price on Omada Health from $26.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Evercore ISI increased their price objective on Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Morgan Stanley set a $32.00 target price on Omada Health in a research report on Thursday, December 18th. Wells Fargo & Company started coverage on Omada Health in a research report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 price target for the company. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a research note on Wednesday, October 8th.

Omada Health Stock Up 3.0%

Shares of OMDA stock opened at $16.12 on Friday. Omada Health has a 12-month low of $14.14 and a 12-month high of $28.40. The firm has a fifty day moving average of $16.86 and a 200-day moving average of $19.96. The company has a market capitalization of $933.51 million and a price-to-earnings ratio of -64.48.

Insider Buying and Selling at Omada Health

In other news, CEO Sean P. Duffy sold 40,796 shares of the stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $15.95, for a total transaction of $650,696.20. Following the completion of the transaction, the chief executive officer directly owned 126,644 shares in the company, valued at $2,019,971.80. This represents a 24.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the transaction, the president owned 69,079 shares of the company’s stock, valued at $1,114,244.27. The trade was a 7.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 276,893 shares of company stock worth $4,336,787 over the last quarter.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Sanofi bought a new position in Omada Health in the second quarter valued at approximately $9,606,000. Teacher Retirement System of Texas bought a new position in shares of Omada Health in the second quarter valued at $640,000. Jennison Associates LLC acquired a new position in Omada Health during the second quarter worth $4,580,000. Emerald Advisers LLC bought a new stake in Omada Health during the second quarter worth $5,089,000. Finally, Emerald Mutual Fund Advisers Trust acquired a new stake in Omada Health in the second quarter valued at $2,950,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.